2022 AACC News
Video from AACC: Fluxergy's multimodal testing platform
August 2, 2022 -- Fluxergy president and co-founder Tej Patel sat down with us at AACC 2022 and discussed the company’s multimodal, multiomic platform that enables doctors to perform different kinds of tests, including reverse transcription polymerase chain reaction and serology tests, using a single instrument and software program.
August 2, 2022 -- Fluxergy president and co-founder Tej Patel sat down with us at AACC 2022 and discussed the company’s multimodal, multiomic platform that enables doctors to perform different kinds of tests, including reverse transcription polymerase chain reaction and serology tests, using a single instrument and software program.
Video from AACC: First impressions, Day 1
August 2, 2022 -- Reflecting on highlights from the LabPulse.com and ScienceBoard.net team for Day 1, Kalorama Information's Bruce Carlson compares AACC 2022 with previous meetings.
August 2, 2022 -- Reflecting on highlights from the LabPulse.com and ScienceBoard.net team for Day 1, Kalorama Information's Bruce Carlson compares AACC 2022 with previous meetings.
Video from AACC: PerkinElmer on diagnostics, acquisitions
August 2, 2022 -- Greg Stock, general manager of PerkinElmer’s Euroimmun business, discussed products and technologies on display at AACC 2022, as well as the integration of acquired companies such as Oxford Immunotec.
August 2, 2022 -- Greg Stock, general manager of PerkinElmer’s Euroimmun business, discussed products and technologies on display at AACC 2022, as well as the integration of acquired companies such as Oxford Immunotec.
Video from AACC: Beckman Coulter partners with Scopio
August 1, 2022 -- Danaher’s Beckman Coulter Diagnostics has announced it has partnered with Scopio Labs to accelerate adoption of Scopio's next-generation peripheral blood smear platforms.
August 1, 2022 -- Danaher’s Beckman Coulter Diagnostics has announced it has partnered with Scopio Labs to accelerate adoption of Scopio's next-generation peripheral blood smear platforms.
Video from AACC: Enzo BioChem CEO on COVID-19 test landscape
August 1, 2022 -- Enzo BioChem develops diagnostic tests and provides testing in centers throughout New York and its surrounding areas. CEO Hamid Erfanian spoke to us at AACC 2022 about the changes he sees in the in vitro diagnostics landscape as the COVID-19 pandemic evolves.
August 1, 2022 -- Enzo BioChem develops diagnostic tests and provides testing in centers throughout New York and its surrounding areas. CEO Hamid Erfanian spoke to us at AACC 2022 about the changes he sees in the in vitro diagnostics landscape as the COVID-19 pandemic evolves.
Video from AACC: AACC president on Theranos, VALID Act
August 1, 2022 -- Dr. Stephen Master, president of the American Association for Clinical Chemistry, provided his thoughts about the main highlights of the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo held this week in Chicago.
August 1, 2022 -- Dr. Stephen Master, president of the American Association for Clinical Chemistry, provided his thoughts about the main highlights of the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo held this week in Chicago.
Video from AACC: Cytovale immune-response test for sepsis
July 29, 2022 -- Cytovale CEO Ajay Shah discusses unmet needs in the sepsis testing market and the firm’s 10-minute direct-from-blood IntelliSep test.
July 29, 2022 -- Cytovale CEO Ajay Shah discusses unmet needs in the sepsis testing market and the firm’s 10-minute direct-from-blood IntelliSep test.
Seegene outlines expansion strategies at AACC 2022
July 29, 2022 -- Seegene provided a glimpse of its global expansion initiatives at the 2022 American Association of Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo in Chicago, held July 26-28.
July 29, 2022 -- Seegene provided a glimpse of its global expansion initiatives at the 2022 American Association of Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo in Chicago, held July 26-28.
Video from AACC: Cloud-connected point-of-care diagnostics
July 28, 2022 -- Lonnie Adelman, CEO and founder of iAssay, and Dean Wong, investor and advisor to the firm, talked to LabPulse.com (sister site of ScienceBoard.net) about the importance of cloud-connected point-of-care diagnostics, which enables the testing of people wherever they are and the conservation of data from testing.
July 28, 2022 -- Lonnie Adelman, CEO and founder of iAssay, and Dean Wong, investor and advisor to the firm, talked to LabPulse.com (sister site of ScienceBoard.net) about the importance of cloud-connected point-of-care diagnostics, which enables the testing of people wherever they are and the conservation of data from testing.
Video from AACC: Reducing sequencing complexity
July 28, 2022 -- Clear Labs Chief Commercial Officer Jeff Field and Director of Assay Development Prasanna Thwar sat down with LabPulse.com (sister site of ScienceBoard.net) to discuss the launch of a platform that makes DNA sequencing easier by integrating robotic automation and cloud-based computing.
July 28, 2022 -- Clear Labs Chief Commercial Officer Jeff Field and Director of Assay Development Prasanna Thwar sat down with LabPulse.com (sister site of ScienceBoard.net) to discuss the launch of a platform that makes DNA sequencing easier by integrating robotic automation and cloud-based computing.
Video from AACC: Siemens Healthineers’ NAFLD test
July 28, 2022 -- Siemens Healthineers CMO Charles Cooper spoke to LabPulse.com (sister site of ScienceBoard.net) about the firm’s Enhanced Liver Fibrosis blood test and how it can be used to assess the risk of nonalcoholic fatty liver disease (NAFLD) progression and liver-related events.
July 28, 2022 -- Siemens Healthineers CMO Charles Cooper spoke to LabPulse.com (sister site of ScienceBoard.net) about the firm’s Enhanced Liver Fibrosis blood test and how it can be used to assess the risk of nonalcoholic fatty liver disease (NAFLD) progression and liver-related events.
Video from AACC: Highlights of Day 3
July 28, 2022 -- Highlights from the LabPulse.com (sister site of ScienceBoard.net) team for Day 3 of the American Association for Clinical Chemistry (AACC) 2022 Chicago meeting.
July 28, 2022 -- Highlights from the LabPulse.com (sister site of ScienceBoard.net) team for Day 3 of the American Association for Clinical Chemistry (AACC) 2022 Chicago meeting.
Video from AACC: Thermo Fisher CMO on the future of diagnostics
July 28, 2022 -- Thermo Fisher Scientific featured a broad array of diagnostic testing products at AACC 2022. Chief Medical Officer (CMO) Manoj Gandhi caught up with ScienceBoard.net's sister site LabPulse.com to discuss shifts in the diagnostic testing landscape.
July 28, 2022 -- Thermo Fisher Scientific featured a broad array of diagnostic testing products at AACC 2022. Chief Medical Officer (CMO) Manoj Gandhi caught up with ScienceBoard.net's sister site LabPulse.com to discuss shifts in the diagnostic testing landscape.
Video from AACC: BrightInsight's Connected Diagnostics Platform
July 28, 2022 -- BrightInsight has launched the Connected Diagnostics Platform for the in vitro diagnostics manufacturer and the laboratory. The platform consists of four tools: Proxy Agent, Analytics Dashboards, Integration Middleware, and Workflow Portals.
July 28, 2022 -- BrightInsight has launched the Connected Diagnostics Platform for the in vitro diagnostics manufacturer and the laboratory. The platform consists of four tools: Proxy Agent, Analytics Dashboards, Integration Middleware, and Workflow Portals.
Video from AACC: Lab Ordering Cloud software
July 27, 2022 -- Mehdi Maghsoodnia, CEO of 1health, spoke to ScienceBoard.net's sister site LabPulse.com about the market needs for the firm’s Lab Ordering Cloud, as well as diagnostic industry trends.
July 27, 2022 -- Mehdi Maghsoodnia, CEO of 1health, spoke to ScienceBoard.net's sister site LabPulse.com about the market needs for the firm’s Lab Ordering Cloud, as well as diagnostic industry trends.
Siemens Healthineers unveils in vitro diagnostics systems at AACC 2022
July 27, 2022 -- At AACC 2022 on Tuesday, Siemens Healthineers unveiled the Atellica CI 1900 Analyzer, a clinical chemistry and immunoassay testing system and lower volume version of its on-the-market Atellica clinical chemistry and immunoassay testing solution.
July 27, 2022 -- At AACC 2022 on Tuesday, Siemens Healthineers unveiled the Atellica CI 1900 Analyzer, a clinical chemistry and immunoassay testing system and lower volume version of its on-the-market Atellica clinical chemistry and immunoassay testing solution.
Drug test detects possibly toxic cannabis derivative
July 27, 2022 -- As the cannabis derivative delta-8-THC grows in popularity, drug tests are needed to detect and differentiate it from delta-9-THC, the primary psychoactive ingredient in cannabis.
July 27, 2022 -- As the cannabis derivative delta-8-THC grows in popularity, drug tests are needed to detect and differentiate it from delta-9-THC, the primary psychoactive ingredient in cannabis.
Method shown to rapidly identify children’s UTIs
July 27, 2022 -- A team led by Dr. Jingcai Wang of Nationwide Children’s Hospital in Columbus, Ohio, has shown that a faster method for diagnosing urinary tract infections (UTIs) in adults could also work in children.
July 27, 2022 -- A team led by Dr. Jingcai Wang of Nationwide Children’s Hospital in Columbus, Ohio, has shown that a faster method for diagnosing urinary tract infections (UTIs) in adults could also work in children.
NGS detects mutation that causes spinal muscular atrophy
July 27, 2022 -- Gustavo Barcelos Barra and colleagues at Sabin Medicina Diagnostica in Brasilia, Brazil, are developing a next-generation sequencing (NGS) panel that detects a mutation in a small spot on the SMN1 gene which causes spinal muscular atrophy.
July 27, 2022 -- Gustavo Barcelos Barra and colleagues at Sabin Medicina Diagnostica in Brasilia, Brazil, are developing a next-generation sequencing (NGS) panel that detects a mutation in a small spot on the SMN1 gene which causes spinal muscular atrophy.
Studies uncover findings on antibody responses, immunity
July 26, 2022 -- Findings from two studies add to a growing body of knowledge that is essential for guiding public health initiatives and might one day enable clinicians to assess individuals’ immunity to SARS-CoV-2, according to AACC.
July 26, 2022 -- Findings from two studies add to a growing body of knowledge that is essential for guiding public health initiatives and might one day enable clinicians to assess individuals’ immunity to SARS-CoV-2, according to AACC.
Improving kidney stone analysis, treatment with AI
July 26, 2022 -- To improve diagnosis and better guide treatment, researchers led by Patrick Day of the Mayo Clinic have developed artificial intelligence (AI)-trained algorithms that analyze the results of kidney stone composition from Fourier transform infrared spectroscopy.
July 26, 2022 -- To improve diagnosis and better guide treatment, researchers led by Patrick Day of the Mayo Clinic have developed artificial intelligence (AI)-trained algorithms that analyze the results of kidney stone composition from Fourier transform infrared spectroscopy.
Smartphone app, blood test may predict clotting risk
July 26, 2022 -- A team of researchers led by Dr. Kelly Michaelsen of the University of Washington is developing a test that could quickly and inexpensively determine prothrombin time/international normalized ratio and clotting risk using a smartphone.
July 26, 2022 -- A team of researchers led by Dr. Kelly Michaelsen of the University of Washington is developing a test that could quickly and inexpensively determine prothrombin time/international normalized ratio and clotting risk using a smartphone.
Cytovale to present new data on rapid sepsis test at AACC
July 25, 2022 -- Cytovale said Monday that it will present new data at AACC 2022 about its 10-minute IntelliSep test for sepsis and its associated system.
July 25, 2022 -- Cytovale said Monday that it will present new data at AACC 2022 about its 10-minute IntelliSep test for sepsis and its associated system.
LumiraDx to discuss microfluidic technology at AACC
July 25, 2022 -- LumiraDx announced that it will host an industry workshop at AACC 2022 on Wednesday, describing the impact of its microfluidic technology on lateral-flow antigen tests and the role of these rapid immunoassays in the response to the COVID-19 pandemic.
July 25, 2022 -- LumiraDx announced that it will host an industry workshop at AACC 2022 on Wednesday, describing the impact of its microfluidic technology on lateral-flow antigen tests and the role of these rapid immunoassays in the response to the COVID-19 pandemic.
BrightInsight launches digital diagnostics platform at AACC
July 25, 2022 -- BrightInsight on Monday announced the launch of its digital Connected Diagnostics Platform at the 2022 AACC Annual Scientific Meeting and Clinical Lab Expo in Chicago.
July 25, 2022 -- BrightInsight on Monday announced the launch of its digital Connected Diagnostics Platform at the 2022 AACC Annual Scientific Meeting and Clinical Lab Expo in Chicago.
DiaSorin nabs FDA clearance for infectious disease blood test
July 22, 2022 -- Saluggia, Italy-based DiaSorin on Friday announced that it has obtained U.S. Food and Drug Administration (FDA) clearance for the Liaison MeMed BV, its host-protein signature-based assay.
July 22, 2022 -- Saluggia, Italy-based DiaSorin on Friday announced that it has obtained U.S. Food and Drug Administration (FDA) clearance for the Liaison MeMed BV, its host-protein signature-based assay.
Companies announce new products ahead of AACC 2022
July 22, 2022 -- Several companies have announced the launch of laboratory diagnostic products in advance of AACC 2022.
July 22, 2022 -- Several companies have announced the launch of laboratory diagnostic products in advance of AACC 2022.
AACC sees rise in impact of medical laboratory journal
July 21, 2022 -- AACC recently announced that the impact factor of its journal Clinical Chemistry has risen to 12.167 in the 2021 Clarivate Journal Citation Reports.
July 21, 2022 -- AACC recently announced that the impact factor of its journal Clinical Chemistry has risen to 12.167 in the 2021 Clarivate Journal Citation Reports.
Beckman, Scopio to partner on blood smear platforms
July 21, 2022 -- Beckman Coulter Diagnostics on Wednesday announced that it has partnered with Scopio Labs to accelerate adoption of Scopio's next-generation peripheral blood smear platforms.
July 21, 2022 -- Beckman Coulter Diagnostics on Wednesday announced that it has partnered with Scopio Labs to accelerate adoption of Scopio's next-generation peripheral blood smear platforms.
Survey finds low morale among lab professionals
July 21, 2022 -- Lighthouse Lab Services on Wednesday announced the results of its first wage and morale survey of medical laboratory professionals, saying that despite receiving modest compensation increases compared to last year, most respondents feel overworked and are performing in understaffed labs.
July 21, 2022 -- Lighthouse Lab Services on Wednesday announced the results of its first wage and morale survey of medical laboratory professionals, saying that despite receiving modest compensation increases compared to last year, most respondents feel overworked and are performing in understaffed labs.
The 2022 AACC Annual Scientific Meeting & Clinical Lab Expo is the premier global scientific conference and expo for the field of laboratory medicine. At this dynamic meeting, you will have the opportunity to:
- Connect with global leaders in clinical chemistry, molecular diagnostics, mass spectrometry, data analytics, translational medicine, lab management, and other areas of breaking science in laboratory medicine.
- Learn about the breakthrough innovations shaping the future of clinical testing and patient care and visit with 750+ exhibitors in person for the solutions to your lab related needs.
- Hear vital research and learn about important changes in the field. With over 250 educational opportunities, you can design an educational experience that meets your need to stay ahead of changes in the field.
To register for 2022 AACC, visit the conference website.
In-person scientific conference registrants will obtain access to the following:
- Scientific Sessions
- Plenary and Meet-the-Experts
- Late Breaking Session - Theranos Whistleblowers
- Sunday Special Session - How Low is too Low?
- Special Competitions
- AACC Clinical Lab Expo
Highlights
Erika Cheung and Tyler Shultz, two of the whistleblowers who helped bring down Theranos, will speak in a fireside chat at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago on Tuesday, July 26, at 1 p.m. U.S. Central Time. The fireside chat comes in the wake of recent fraud convictions for Theranos executives Elizabeth Holmes and Ramesh Balwani.
The Verifying Accurate Leading-edge IVCT Development (VALID) Act would significantly alter the regulation of laboratory developed tests (LDTs). If enacted, VALID would create new duplicative FDA requirements for laboratories that perform LDTs on top of the already stringent regulatory framework overseen by the Centers for Medicare and Medicaid Services (CMS) through the Clinical Laboratory Improvement Amendments (CLIA). Throughout 2022, AACC's primary advocacy focus has been on preventing the passage of the Act.
A scientific session on July 25 will cover the legislation Congress has introduced and the potential impact on laboratory medicine. The session, "VALID, VITAL, LDT" will be led by experts with experience in both advocacy and LDTs in the lab.
During the COVID-19 pandemic, clinical laboratories across the world have been challenged in many ways, including having to contend with clinically significant variability in test results that are amplified at the international level.
How labs are dealing with these challenges will be discussed during a roundtable session, "Clinical Laboratory Leadership and Management During a Pandemic: A Global Perspective," on Tuesday, July 26 at the 2022 AACC Annual Scientific Meeting in Chicago.
Dr. Barnali Das, consultant in laboratory medicine for Kokilaben Dhirubhai Ambani Hospital in Mumbai, India, will explore effective leadership strategies for process re-engineering, time management, resource and personnel management, team development, strategic planning, global harmonization, and cost of ownership.